Back to Search
Start Over
[Tuberculous Meningitis in Which Inflammation Cannot Be Adequately Suppressed by Standard Therapy: Treatment-Resistant Tuberculous Meningitis]
- Source :
- Brain and nerve = Shinkei kenkyu no shinpo. 74(5)
- Publication Year :
- 2022
-
Abstract
- To understand tuberculous meningitis (TBM), its clinical features and standard therapy were briefly reviewed. In addition, to determine the therapeutic strategies for treatment-resistant TBM, several clinical cases, including those with paradoxical reaction, ventriculitis, cerebral tuberculoma, and human immunodeficiency virus (HIV) co-infection, are presented. Steroid pulse therapy and intrathecal isoniazid administration are discussed as specific therapeutic strategies. Immune reconstitution inflammatory syndrome in patients with TBM suffering from HIV co-infection and alternative drug selection for drug-resistant TBM cases are also introduced. Although TMB is a rare central nervous system infection, it remains a serious disease with high rates of mortality and neurological sequelae. Knowing therapeutic strategies for treatment-resistant TBM is necessary to prevent a devastating prognosis.
- Subjects :
- Inflammation
Coinfection
Tuberculosis, Meningeal
Humans
HIV Infections
Subjects
Details
- ISSN :
- 18816096
- Volume :
- 74
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Brain and nerve = Shinkei kenkyu no shinpo
- Accession number :
- edsair.pmid..........609a931ee248aabf0ae8e0141beae4a4